Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial

M Fleseriu, R Pivonello, A Elenkova, R Salvatori, RJ Auchus, R.A. Feelders, EB Geer, Y Greenman, P Witek, F Cohen, BMK Biller

Research output: Contribution to journalArticleAcademicpeer-review

63 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)855-865
Number of pages11
JournalThe Lancet Diabetes & Endocrinology
Issue number11
Publication statusPublished - 2019

Research programs

  • EMC MM-01-39-01

Cite this